How Long Should You Stay on a GLP-1? (2026 Guide)

What the trials show about stopping

The STEP-4 trial gave everyone semaglutide 2.4 mg for 20 weeks, then randomly assigned them to continue or switch to placebo. Over the next 48 weeks, patients who continued lost an additional 7.9%; patients switched to placebo regained 6.9% — a net difference of nearly 15 percentage points.

SURMOUNT-4 ran the same design for tirzepatide. Continued treatment: additional 5.5% weight loss. Placebo switch: 14% regain.

The takeaway: appetite regulation reverts when the drug stops. Weight regain is not a failure of willpower — it's the underlying biology reasserting itself.

The obesity-as-chronic-disease framing

Every major medical society now treats obesity as a chronic condition, like hypertension. You don't stop a blood pressure medication when your blood pressure normalizes; you take it because it's working. GLP-1 clinicians increasingly apply the same framing.

Can you take a lower maintenance dose?

Emerging clinical practice: after 12–24 months at a max tolerated dose with stable weight, some clinicians step patients down to the next-lower dose (e.g., Wegovy 1.7 mg or Zepbound 10 mg) and monitor for regain. Data on this is thinner but real-world experience is encouraging — many patients maintain on a lower dose, with lower cost and fewer side effects.

A related strategy: extended dosing intervals (every 10–14 days instead of weekly) at a low dose. Not officially endorsed but reported by some clinicians.

When it makes sense to stop

• Serious adverse events (pancreatitis, severe gallbladder disease)
• Pregnancy or trying to conceive (stop 2 months before)
• Financial reasons — sometimes an unavoidable trigger
• Achieving a specific short-term goal (surgery weight requirement, fertility treatment)

How to stop with the best chance of holding weight

1. Taper slowly. Step down one dose level at a time over 3–6 months rather than stopping abruptly.
2. Lock in habits before you taper. Consistent protein, resistance training, sleep, and step count should be automatic before the drug comes off.
3. Weigh weekly. Early regain is a signal to reintroduce the medication or slow the taper — not a moral failing.
4. Have a plan to restart. Discuss with your clinician what would trigger going back on.

Cycling on and off

Some patients cycle — 6–12 months on for weight loss, off for maintenance, back on if regain starts. This can work but is more expensive and less studied than continuous use. Talk to your clinician about whether it's realistic given your history.

What about semaglutide "vacations"?

Short breaks (a week or two) generally don't cause meaningful weight regain but also don't help anything — appetite bounces back within days. Longer breaks (1+ months) predictably lead to regain.

Cost of long-term use

At $500–$1,000/month, indefinite use is a serious financial commitment. For patients with commercial insurance that covers it, copays are manageable. Cash-pay users often transition to lower-cost compounded semaglutide for maintenance or step down to a lower brand-name dose to stretch their budget.

Realistic expectations

• Weight loss typically plateaus at 12–18 months at max tolerated dose.
• Most patients maintain that new weight as long as they stay on the drug and eat with intention.
• Stopping without a robust lifestyle plan generally leads to two-thirds regain within a year.
• A small subset can hold weight long-term after stopping — usually those who transitioned into strength training and structured eating during the treatment period.

FAQ